229 related articles for article (PubMed ID: 31384305)
21. N-MYC Downstream Regulated Gene 4 (
Cao L; Hu T; Lu H; Peng D
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927604
[TBL] [Abstract][Full Text] [Related]
22. High expression of NDRG3 correlates with poor prognosis in gastric cancer patients.
Liu Y; Xia J; Zhou Y; Shao S
Rev Esp Enferm Dig; 2021 Jul; 113(7):524-528. PubMed ID: 33562989
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
24. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
25. NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia.
Yamamoto H; Kokame K; Okuda T; Nakajo Y; Yanamoto H; Miyata T
J Biol Chem; 2011 Jul; 286(29):26158-65. PubMed ID: 21636852
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of signal transducers activators of transcription in gastric cancer.
Zhang Y; Yu C
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944204
[TBL] [Abstract][Full Text] [Related]
27. The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery.
Sasaki T; Nakamura Y; Hata S; Shimada H
Anticancer Res; 2023 Jul; 43(7):2965-2974. PubMed ID: 37351994
[TBL] [Abstract][Full Text] [Related]
28. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
29. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
[TBL] [Abstract][Full Text] [Related]
30. The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications.
Melotte V; Qu X; Ongenaert M; van Criekinge W; de Bruïne AP; Baldwin HS; van Engeland M
FASEB J; 2010 Nov; 24(11):4153-66. PubMed ID: 20667976
[TBL] [Abstract][Full Text] [Related]
31. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
32. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
33. NDRG1 suppresses vasculogenic mimicry and tumor aggressiveness in gastric carcinoma.
Dong X; Hong Y; Sun H; Chen C; Zhao X; Sun B
Oncol Lett; 2019 Sep; 18(3):3003-3016. PubMed ID: 31452779
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
35. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3.
Murray JT; Campbell DG; Morrice N; Auld GC; Shpiro N; Marquez R; Peggie M; Bain J; Bloomberg GB; Grahammer F; Lang F; Wulff P; Kuhl D; Cohen P
Biochem J; 2004 Dec; 384(Pt 3):477-88. PubMed ID: 15461589
[TBL] [Abstract][Full Text] [Related]
36. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
37. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
Front Oncol; 2020; 10():603480. PubMed ID: 33425760
[TBL] [Abstract][Full Text] [Related]
38. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.
Jing JS; Li H; Wang SC; Ma JM; Yu LQ; Zhou H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413609
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
